Læknaneminn - 01.04.2004, Qupperneq 46

RITGERÐ I LYFJAFRÆÐI
4. Barnes PJ. Inhaled Glucocorticoids for Asthma. N Engl J Med 1995; 332;
868-875.
5. Spahn J. Use of glucocorticoids in the treatment of asthma. UpToDate (onlíne)
2002 an-Sep (cited 2003 Feb 11). Avaílable from: URL: http://www.utdol.com/
application/topic.asp?file=asthma/10384&type=A&selectedTitle=5~72
6. Spahn J. Mechnism of actíon and pharmacology of glucocorticoid therapy
in asthma. UpToDate (online) 2002 an-Jul (cited 2003 Jan 27). Available
from: URL: http://www. utdol.com /application/topic.asp?file=asthma/
10563&type=A&selectedTitle=2~72
7. Adcock IM, Caramori G. Cross-talk between pro-inflammatory transcription
factors and glucocorticoids. Immunol Cell Biol 2001; 79: 376.
8. Kagoshima M, Wilcke T, Ito K et al. Glucocorticoid-mediated transrepression
is regulated by histone acetylation and DNA methylation. European Journal of
Pharmacology 2001; 429: 327-334.
9. de Haíj S, Adcock IM, Bakker AC, Gobin SJP, Daha MR, van Kooten C. Steroíd-
responsiveness of renal epithelial cells: Dissociation of trans-repressíon and trans-
activation. Journal of Biological Chemistry 2003; 278: 5091.
10. Lee TH. Glucocorticoid-resistant asthma. UpToDate (online) 2002 an-May
(cited 2003 Feb 11). Available from: URL: http://www.utdol.com/application/
topic.asp?file=asthma/2299&type=A&selectedTitle=1~4
11. John M, Lim S, Seybold J et al. Inhaled Corticosteroids Increase Interleukin-
10 but Reduce Macrophage Inflammatory Protein-1a, Granulocyte-Macrophage
Colony-Stimulating Factor, and Interferon-y Release from Alveolar Macrophages
in Asthma. Am J Respir Crit Care Med 1998; 157: 256-262.
12. Chung KF, Barnes PJ. Cytokines in asthma. Thorax 1999; 54: 825-857,
13. Janeway CA„ Travers P, Walport M, Shlomchik MJ. Immunobiology. The
immune system in health and disease. New York: Garland Publishing, 2001: 35-
88, 554-555.
14. The Childhood Asthma Management Program Research Group, Long-Term
Effects of Budesonide or Nedocromil in Chíldren with Asthma. N Engl J Med 2000;
343: 1054-1063.
15. Editors: Schleimer RP, O’Byrne PM, Szefler SJ, Brattsand R. Inhaled Steroids
in Asthma. Optimizing Effects in the Airways. New York: Marcel Dekker Inc., 2002:
389-413.
16. Saag KG, Furst DE, Drazen JM, Major side effects of inhaled glucocorticoids.
UpToDate (online) 2002 an-May (cited 2003 Jan 27), Avaílable from:
URL: http://www.utdoi.com/appiication/topic.asp?fiie=rheumati/
34351 &type=A&seiectedTitie=1 ~72
17. Agertoft L, Pedersen S. Effect of Long-Term Treatment with Inhaled
Budesonide on Adult Height in Children with Asthma. N Engl J Med 2000; 343:
1064-1069.
18. Israel E, Banerjee TR, Fitzmaurice GM, Kotlov TV, LaHive K, LeBoff MS. Effects
of Inhaied Glucocorticoids on Bone Density in Premenopausal Women. N Engl J
Med 2001;345:941-947.
19. Leung DY, Martin RJ, Szefler SJ, Sher ER, Ying S, Kay AB, Hamid Q.
Dysregulation of interleukin-4, interleukin-5 and interferon gamma gene expression
in steroid-resistant asthma. J Exp Med 1995; 181: 33-40,
20. Bamberger CM, Bamberger AM, de Castro M, Chrousos GP. Glucocorticoid
receptor beta, a potential endogenous inhibitor of glucocorticoid action in humans,
J Clin Invest 1995; 95: 2435-2441.
21. Hakonarson H, Bjornsdottir US, Halapi E et al. Prediction of glucocorticoid
responsiveness by gene expression profiles (running title). Manus under review
2003.
22. Helgadottir H, Bjornsdottir US, Halapi E et al. Gene array analysis of PBM
cells from asthmatic patients with variable glucocorticoid sensitívity. J Allergy Clin
Immunolog 2002; 109: 173.
Óskum eftir starfskröftum ykkar.
Þið eruð velkomin í heimsókn
til að skoða og kynnast starfs-
aðstöðu á heimilunum.
Upplýsingar veita hjúkrunar-
forstjórar, einnig er hægt að
sækja um starf á heimasíðu
Hrafnistu
Hrafnista
í Reykjavík og Hafnarfirði
www. h raf n ista. i s
46 - L.æknaneminn 2004